WFDC2 and ovarian carcinoma: Combining CA125 and HE4 at a cut-off of 70 pmol/L achieved a sensitivity of 76% and a specificity of 100% for detecting ovarian cancer recurrence, compared to a sensitivity of 35% and a specificity of 59% when relying solely on CA125 [18].